Waters (WAT) 8-K Sales of $819 million declined 4.5% as reported and 8% in organic constant currency, in line with guidance

Exhibit 99.1

For Immediate Release

Contact: Caspar Tudor, Head of Investor Relations – (508) 482-2429

Waters Corporation (NYSE: WAT) Reports Fourth Quarter

and Full-Year 2023 Financial Results

Highlights

Fourth Quarter 2023

• Sales of $819 million declined 4.5% as reported and 8% in organic constant currency, in line with guidance

• Operational excellence drove gross margin expansion of 170 basis points and adjusted operating margin expansion of 120 basis points

• Non-GAAP EPS of $3.62 at the high end of guidance; GAAP EPS of $3.65

Full-Year 2023

• Strong execution in tough market conditions delivered sales of $2,956 million, a decline of 0.5% as reported and 2% in organic constant currency, as expected

• Wyatt acquisition delivered an on-target M&A contribution of 2.5% to sales

• Gross margin expanded 160 basis points to 59.6% and adjusted operating margin expanded 70 basis points to 30.9%

MILFORD, Mass., February 6, 2024 - Waters Corporation (NYSE: WAT) today announced its financial results for the fourth quarter and full-year 2023.

Sales for the fourth quarter of 2023 were $819 million, a decrease of 4.5% as reported, compared to sales of $859 million for the fourth quarter of 2022. Currency translation had minimal impact on sales, while the impact of acquisitions increased sales by more than 3%.

On a GAAP basis, diluted earnings per share (EPS) for the fourth quarter of 2023 were $3.65, compared to $3.81 for the fourth quarter of 2022. On a non-GAAP basis, EPS was $3.62, compared to $3.84 for the fourth quarter of 2022. This includes a headwind of approximately 2% due to unfavorable foreign exchange.

For fiscal year 2023, the Company’s sales were $2,956 million, a decrease of 0.5% as reported, compared to sales of $2,972 million for fiscal year 2022. Currency translation decreased sales by approximately 1%, while the impact of acquisitions increased sales by 2.5%.

On a GAAP basis, EPS for fiscal year 2023 was $10.84, compared to $11.73 for fiscal year 2022. On a non-GAAP basis, EPS was $11.75, compared to $12.02 in fiscal year 2022. This includes a headwind of approximately 3% due to unfavorable foreign exchange and a 1% dilution from the Wyatt acquisition.

“Waters results in 2023 demonstrate our teams’ strong focus on execution, the competitiveness of our new products, and the resilience of demand in QA/QC and high-volume applications,” said Dr. Udit Batra, President & CEO, Waters Corporation. “Our focus on operational excellence helped us to deliver exceptional margin expansion even in difficult market conditions.”

Dr. Batra continued, “The year ended with our business benefitting from an expected increase in sales in Q4 versus that of Q3, a testament to our teams’ commitment to innovation that addresses our customers’ greatest needs. We also reached a new chapter in our transformation in 2023 with the acquisition of Wyatt. We have made very good progress integrating the team, achieving our target sales contribution of 2.5% for the year.”

Fourth Quarter 2023

During the fourth quarter of 2023, sales into the pharmaceutical market decreased 6% as reported and 11% in organic constant currency, sales into the industrial market decreased 3% as reported and 4% in organic constant currency, and sales into the academic and government markets decreased 2% as reported and 9% in organic constant currency.

During the quarter, instrument system sales decreased 14% as reported and 20% in organic constant currency, while recurring revenues, which represent the combination of service and precision chemistries, increased 7% as reported and 5% in organic constant currency.

Geographically, sales in Asia during the quarter decreased 18% as reported and 16% in organic constant currency (with China sales declining almost 40%). Sales in the Americas increased 4% as reported and decreased 2% in organic constant currency. Sales in Europe increased 3% as reported and decreased 6% in organic constant currency.

Full-Year 2023

For fiscal year 2023, sales into the pharmaceutical market decreased 3% as reported and 5% in organic constant currency, sales into the industrial market were flat as reported and in organic constant currency, and sales into the academic and government markets increased 13% as reported and 10% in organic constant currency.

For fiscal year 2023, instrument system sales decreased 7% as reported and 10% in organic constant currency, while recurring revenues increased 6% as reported and in organic constant currency.

Geographically, sales in Asia for fiscal year 2023 decreased 11% as reported and 7% in organic constant currency (with China sales declining more than 20%). Sales in the Americas increased 5% as reported and 1% in organic constant currency. Sales in Europe increased 7% as reported and 2% in organic constant currency.

Unless otherwise noted, sales growth and decline percentages are presented on an as-reported basis. A description and reconciliation of GAAP to non-GAAP results appear in the tables below and can be found on the Company’s website www.waters.com in the Investor Relations section.

Full-Year and First Quarter 2024 Financial Guidance

Full-Year 2024 Financial Guidance

The Company expects full-year 2024 organic constant currency sales growth to be in the range of -0.5% to +1.5%. Currency translation is expected to decrease full-year sales growth by approximately 1%. M&A contribution from the Wyatt transaction covering the first four and a half months of the year is expected to increase full-year reported sales growth by 1.3%. The resulting full-year 2024 reported sales growth is expected in the range of 0% to +2%.

The Company expects full-year 2024 non-GAAP EPS to be in the range of $11.75 to $12.05, which includes an estimated headwind of approximately 1% due to unfavorable foreign exchange.

Please refer to the tables below for a reconciliation of the projected GAAP to non-GAAP financial outlook for the full-year.

First Quarter 2024 Financial Guidance

The Company expects first quarter 2024 organic constant currency sales growth to be in the range of -11% to -9%. Currency translation is expected to decrease first quarter sales growth by approximately 1%. The Wyatt transaction is expected to increase first quarter reported sales growth by 3.5%. The resulting first quarter 2024 reported sales growth is expected in the range of -8.5% to -6.5%.

The Company expects first quarter 2024 non-GAAP EPS to be in the range of $2.05 to $2.15, which includes an estimated headwind of approximately 4% due to unfavorable foreign exchange.

Please refer to the tables below for a reconciliation of the projected GAAP to non-GAAP financial outlook for the first quarter.

Conference Call Details

Waters Corporation will webcast its fourth quarter and fiscal year 2023 financial results conference call today, February 6, 2024, at 8:00 a.m. Eastern Time. To listen to the call and see the accompanying slide presentation, please visit www.waters.com, select “Investors” under the “About Waters” section, navigate to “Events & Presentations,” and click on the “Webcast.” A replay will be available through February 20, 2024 on the same website by webcast and also by phone at (866) 363-1805.

About Waters Corporation

Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 60 years. With approximately 8,000 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries. For more information, visit www.waters.com.

Non-GAAP Financial Measures

This press release contains financial measures, such as organic constant currency growth rate, adjusted operating income, adjusted net income, adjusted earnings per diluted share and adjusted free cash flow, among others, which are considered “non-GAAP” financial measures under applicable U.S. Securities and Exchange Commission rules and regulations. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with U.S. generally accepted accounting principles (GAAP). The Company’s definitions of these non-GAAP measures may differ from similarly titled measures used by others. The non-GAAP financial measures used in this press release adjust for specified items that can be highly variable or difficult to predict. The Company generally uses these non-GAAP financial measures to facilitate management’s financial and operational decision-making, including evaluation of the Company’s historical operating results, comparison to competitors’ operating results and determination of management incentive compensation. These non-GAAP financial measures reflect an additional way of viewing aspects of the Company’s operations that, when viewed with GAAP results and the reconciliations to corresponding GAAP financial measures, may provide a more complete understanding of factors and trends affecting the Company’s business. Because non-GAAP financial measures exclude the effect of items that will increase or decrease the Company’s reported results of operations, management strongly encourages investors to review the Company’s consolidated financial statements and publicly filed reports in their entirety. Reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the tables accompanying this release.

Cautionary Statement

This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “feels”, “believes”, “anticipates”, “plans”, “expects”, “intends”, “suggests”, “appears”, “estimates”, “projects” and similar expressions, whether in the negative or affirmative, are intended to identify forward-looking statements. The Company’s actual future results may differ significantly from the results discussed in the forward-looking statements within this release for a variety of reasons, including and without limitation, risks related to, and expectations or ability to realize commercial success of the Wyatt transaction; the impact of this transaction on the Company’s business, anticipated progress on Waters’ research programs, development of new analytical instruments and associated software or consumables, manufacturing development and capabilities; the increased indebtedness of the Company as a result of the Wyatt transaction, the repayment of which could impact the Company’s future results, market prospects for its products and sales and earnings guidance; foreign currency exchange rate fluctuations potentially affecting translation of the Company’s future non-U.S. operating results, particularly when a foreign currency weakens against the U.S. dollar; current global economic, sovereign and political conditions and uncertainties, including the effect of new or proposed tariff or trade regulations; changes in inflation and interest rates; the impacts and costs of war, in particular as a result of the ongoing conflict between Russia and Ukraine and in the Middle East, and the possibility of further escalation resulting in new geopolitical and regulatory instability; the Chinese government’s ongoing tightening of restrictions on procurement by government-funded customers; the Company’s ability to access capital, maintain liquidity and service the Company’s debt in volatile market conditions; changes in timing and demand for the Company’s products among the Company’s customers and various market sectors, particularly as a

result of fluctuations in their expenditures or ability to obtain funding; the ability to realize the expected benefits related to the Company’s various cost-saving initiatives; the introduction of competing products by other companies and loss of market share, as well as pressures on prices from competitors and/or customers; changes in the competitive landscape as a result of changes in ownership, mergers and continued consolidation among the Company’s competitors; regulatory, economic and competitive obstacles to new product introductions; lack of acceptance of new products and inability to grow organically through innovation; rapidly changing technology and product obsolescence; risks associated with previous or future acquisitions, strategic investments, joint ventures and divestitures, including risks associated with contingent purchase price payments and expansion of our business into new or developing markets; risks associated with unexpected disruptions in operations; failure to adequately protect the Company’s intellectual property, infringement of intellectual property rights of third parties and inability to obtain licenses on commercially reasonable terms; the Company’s ability to acquire adequate sources of supply and its reliance on outside contractors for certain components and modules, as well as disruptions to its supply chain; risks associated with third-party sales intermediaries and resellers; the impact and costs of changes in statutory or contractual tax rates in jurisdictions in which the Company operates as well as shifts in taxable income among jurisdictions with different effective tax rates, the outcome of ongoing and future tax examinations and changes in legislation affecting the Company’s effective tax rate; the Company’s ability to attract and retain qualified employees and management personnel; risks associated with cybersecurity and technology, including attempts by third parties to defeat the security measures of the Company and its third-party partners; increased regulatory burdens as the Company’s business evolves, especially with respect to the U.S. Food and Drug Administration and U.S. Environmental Protection Agency, among others, and in connection with government contracts; regulatory, environmental, and logistical obstacles affecting the distribution of the Company’s products, completion of purchase order documentation and the ability of customers to obtain letters of credit or other financing alternatives; risks associated with litigation and other legal and regulatory proceedings; and the impact and costs incurred from changes in accounting principles and practices. Such factors and others are discussed more fully in the sections entitled “Forward-Looking Statements” and “Risk Factors” of the Company’s annual report on Form 10-K for the year ended December 31, 2022, as well as in the sections entitled “Special Note Regarding Forward-Looking Statements” and “Risk Factors” of the Company’s quarterly reports on Form 10-Q for the quarterly periods ended April 1, 2023, July 1, 2023, and September 30, 2023 as filed with the Securities and Exchange Commission (“SEC”), which discussions are incorporated by reference in this release, as updated by the Company’s future filings with the SEC. The forward-looking statements included in this release represent the Company’s estimates or views as of the date of this release and should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this release. Except as required by law, the Company does not assume any obligation to update any forward-looking statements.

Waters Corporation and Subsidiaries

Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

	Three Months Ended						Twelve Months Ended
	December 31, 2023			December 31, 2022			December 31, 2023			December 31, 2022
Net sales	$	819,474		$	858,510		$	2,956,416		$	2,971,956
Costs and operating expenses:
Cost of sales		318,360			348,190			1,195,223			1,248,182
Selling and administrative expenses		180,357			174,257			736,014			658,026
Research and development expenses		44,386			48,277			174,945			176,190
Purchased intangibles amortization		12,148			1,503			32,558			6,366
Acquired in-process research and development		—			—			—			9,797
Operating income		264,223			286,283			817,676			873,395
Other (expense) income, net		(557	)		(372	)		807			2,228
Interest expense, net		(26,066	)		(10,415	)		(82,240	)		(37,777	)
Income from operations before income taxes		237,600			275,496			736,243			837,846
Provision for income taxes		21,395			48,434			94,009			130,091
Net income	$	216,205		$	227,062		$	642,234		$	707,755
Net income per basic common share	$	3.66		$	3.83		$	10.87		$	11.80
Weighted-average number of basic common shares		59,142			59,329			59,076			59,985
Net income per diluted common share	$	3.65		$	3.81		$	10.84		$	11.73
Weighted-average number of diluted common shares and equivalents		59,311			59,644			59,270			60,331

Waters Corporation and Subsidiaries

Reconciliation of GAAP to Adjusted Non-GAAP

Net Sales by Operating Segments, Products & Services, Geography and Markets

Three Months Ended December 31, 2023 and December 31, 2022

(In thousands)

														Organic
														Constant
	Three Months Ended				Percent			Impact of			Impact of			Currency
	December 31, 2023		December 31, 2022		Change			Currency			Acquisitions			Growth Rate (a)
NET SALES - OPERATING SEGMENTS
Waters	$	716,932	$	754,753		(5	%)		0	%		4	%		(9	%)
TA		102,542		103,757		(1	%)		1	%		0	%		(2	%)
Total	$	819,474	$	858,510		(5	%)		0	%		3	%		(8	%)
NET SALES - PRODUCTS & SERVICES
Instruments	$	397,201	$	463,038		(14	%)		1	%		5	%		(20	%)
Service		278,888		255,734		9	%		1	%		2	%		6	%
Chemistry		143,385		139,738		3	%		0	%		0	%		3	%
Total Recurring		422,273		395,472		7	%		0	%		2	%		5	%
Total	$	819,474	$	858,510		(5	%)		0	%		3	%		(8	%)
NET SALES - GEOGRAPHY
Asia	$	261,893	$	319,465		(18	%)		(3	%)		1	%		(16	%)
Americas		303,746		293,118		4	%		0	%		6	%		(2	%)
Europe		253,835		245,927		3	%		6	%		4	%		(6	%)
Total	$	819,474	$	858,510		(5	%)		0	%		3	%		(8	%)
NET SALES - MARKETS
Pharmaceutical	$	463,698	$	492,763		(6	%)		1	%		4	%		(11	%)
Industrial		260,249		267,923		(3	%)		(0	%)		1	%		(4	%)
Academic & Government		95,527		97,824		(2	%)		1	%		7	%		(9	%)
Total	$	819,474	$	858,510		(5	%)		0	%		3	%		(8	%)

(a) The Company believes that referring to comparable organic constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation’s net sales. Organic constant currency growth, a non-GAAP financial measure, measures the change in net sales between current and prior year periods, excluding the impact of foreign currency exchange rates during the current period and excluding the impact of acquisitions made within twelve months of the acquisition close date. See description of non-GAAP financial measures contained in this release.

Waters Corporation and Subsidiaries

Reconciliation of GAAP to Adjusted Non-GAAP

Net Sales by Operating Segments, Products & Services, Geography and Markets

Twelve Months Ended December 31, 2023 and December 31, 2022

(In thousands)

														Organic
														Constant
	Twelve Months Ended				Percent			Impact of			Impact of			Currency
	December 31, 2023		December 31, 2022		Change			Currency			Acquisitions			Growth Rate (a)
NET SALES - OPERATING SEGMENTS
Waters	$	2,601,590	$	2,626,462		(1	%)		(1	%)		3	%		(3	%)
TA		354,826		345,494		3	%		(0	%)		0	%		3	%
Total	$	2,956,416	$	2,971,956		(1	%)		(1	%)		3	%		(2	%)
NET SALES - PRODUCTS & SERVICES
Instruments	$	1,361,581	$	1,462,770		(7	%)		(1	%)		4	%		(10	%)
Service		1,053,366		983,787		7	%		(1	%)		2	%		7	%
Chemistry		541,469		525,399		3	%		(1	%)		0	%		4	%
Total Recurring		1,594,835		1,509,186		6	%		(1	%)		1	%		6	%
Total	$	2,956,416	$	2,971,956		(1	%)		(1	%)		3	%		(2	%)
NET SALES - GEOGRAPHY
Asia	$	1,007,825	$	1,131,743		(11	%)		(4	%)		0	%		(7	%)
Americas		1,108,573		1,055,635		5	%		(0	%)		4	%		1	%
Europe		840,018		784,578		7	%		3	%		3	%		2	%
Total	$	2,956,416	$	2,971,956		(1	%)		(1	%)		3	%		(2	%)
NET SALES - MARKETS
Pharmaceutical	$	1,696,875	$	1,751,665		(3	%)		(1	%)		3	%		(5	%)
Industrial		909,003		909,805		0	%		(1	%)		1	%		0	%
Academic & Government		350,538		310,486		13	%		(1	%)		4	%		10	%
Total	$	2,956,416	$	2,971,956		(1	%)		(1	%)		3	%		(2	%)

(a) The Company believes that referring to comparable organic constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation’s net sales. Organic constant currency growth, a non-GAAP financial measure, measures the change in net sales between current and prior year periods, excluding the impact of foreign currency exchange rates during the current period and excluding the impact of acquisitions made within twelve months of the acquisition close date. See description of non-GAAP financial measures contained in this release.

Waters Corporation and Subsidiaries

Reconciliation of GAAP to Adjusted Non-GAAP Financials

Three and Twelve Months Ended December 31, 2023 and December 31, 2022

(In thousands, except per share data)

	Selling & Administrative Expenses (a)			Acquired IPR&D and Research & Development Expenses			Operating Income		Operating Income Percentage			Other (Expense) Income			Income from Operations before Income Taxes		Provision for Income Taxes			Net Income			Diluted Earnings per Share
Three Months Ended December 31, 2023
GAAP	$	192,505		$	44,386		$	264,223		32.2	%	$	(557	)	$	237,600	$	21,395		$	216,205		$	3.65
Adjustments:
Purchased intangibles amortization (b)		(12,148	)		—			12,148		1.5	%		—			12,148		2,906			9,242			0.16
Restructuring costs and certain other items (d)		(1,036	)		—			1,036		0.1	%		130			1,166		266			900			0.02
Acquisition related costs (e)		(649	)		—			649		0.1	%		—			649		156			493			0.01
Retention bonus obligation (g)		(5,725	)		(1,909	)		7,634		0.9	%		—			7,634		1,832			5,802			0.10
Certain income tax items (f)		—			—			—		—			—			—		17,651			(17,651	)		(0.30	)
Adjusted Non-GAAP	$	172,947		$	42,477		$	285,690		34.9	%	$	(427	)	$	259,197	$	44,206		$	214,991		$	3.62
Three Months Ended December 31, 2022
GAAP	$	175,760		$	48,277		$	286,283		33.3	%	$	(372	)	$	275,496	$	48,434		$	227,062		$	3.81
Adjustments:
Purchased intangibles amortization (b)		(1,503	)		—			1,503		0.2	%		—			1,503		346			1,157			0.02
Restructuring costs and certain other items (d)		(1,364	)		—			1,364		0.2	%		(120	)		1,244		278			966			0.02
Adjusted Non-GAAP	$	172,893		$	48,277		$	289,150		33.7	%	$	(492	)	$	278,243	$	49,058		$	229,185		$	3.84
Twelve Months Ended December 31, 2023
GAAP	$	768,572		$	174,945		$	817,676		27.7	%	$	807		$	736,243	$	94,009		$	642,234		$	10.84
Adjustments:
Purchased intangibles amortization (b)		(32,558	)		—			32,558		1.1	%		—			32,558		7,758			24,800			0.42
Restructuring costs and certain other items (d)		(29,917	)		—			29,917		1.0	%		(521	)		29,396		7,126			22,270			0.38
Acquisition related costs (e)		(13,947	)		—			13,947		0.5	%		—			13,947		3,347			10,600			0.18
Retention bonus obligation (g)		(14,093	)		(4,699	)		18,792		0.6	%		—			18,792		4,510			14,282			0.24
Certain income tax items (f)		—			—			—		—			—			—		17,651			(17,651	)		(0.30	)
Adjusted Non-GAAP	$	678,057		$	170,246		$	912,890		30.9	%	$	286		$	830,936	$	134,401		$	696,535		$	11.75
Twelve Months Ended December 31, 2022
GAAP	$	664,392		$	185,987		$	873,395		29.4	%	$	2,228		$	837,846	$	130,091		$	707,755		$	11.73
Adjustments:
Purchased intangibles amortization (b)		(6,366	)		—			6,366		0.2	%		—			6,366		1,461			4,905			0.08
Acquired in-process research and development (c)		—			(9,797	)		9,797		0.3	%		—			9,797		2,351			7,446			0.12
Restructuring costs and certain other items (d)		(8,551	)		—			8,551		0.3	%		(3,273	)		5,278		1,186			4,092			0.07
Certain income tax items (f)		—			—			—		—			—			—		(994	)		994			0.02
Adjusted Non-GAAP	$	649,475		$	176,190		$	898,109		30.2	%	$	(1,045	)	$	859,287	$	134,095		$	725,192		$	12.02

(a) Selling & administrative expenses include purchased intangibles amortization.

(b) The purchased intangibles amortization, a non-cash expense, was excluded to be consistent with how management evaluates the performance of its core business against historical operating results and the operating results of competitors over periods of time.

(c) Acquired in-process research and development was excluded as it relates to the cost of a licensing arrangement for charge detection mass spectrometry that the Company believes is unusual and not indicative of its normal business operations.

(d) Restructuring costs and certain other items were excluded as the Company believes that the cost to consolidate operations, reduce overhead, and certain other income or expense items are not normal and do not represent future ongoing business expenses of a specific function or geographic location of the Company.

(e) Acquisition related costs include all incremental expenses incurred, such as advisory, legal, accounting, tax, valuation, and other professional fees. The Company believes that these costs are not normal and do not represent future ongoing business expenses.

(f) Certain income tax items were excluded as these non-cash expenses and benefits represent updates in management’s assessment of ongoing examinations, tax audit settlements, or other tax items that are not indicative of the Company’s normal or future income tax expense.

(g) In connection with the Wyatt acquisition, the Company started to recognize a two-year retention bonus obligation that is contingent upon the employee’s providing future service and continued employment with Waters. The Company believes that these costs are not normal and do not represent future ongoing business expenses.

Waters Corporation and Subsidiaries

Preliminary Condensed Unclassified Consolidated Balance Sheets

(In thousands and unaudited)

	December 31, 2023		December 31, 2022
Cash, cash equivalents and investments	$	395,974	$	481,391
Accounts receivable		702,168		722,892
Inventories		516,236		455,710
Property, plant and equipment, net		639,073		582,217
Intangible assets, net		629,187		227,399
Goodwill		1,305,446		430,328
Other assets		438,770		381,516
Total assets	$	4,626,854	$	3,281,453
Notes payable and debt	$	2,355,513	$	1,574,878
Other liabilities		1,121,000		1,202,087
Total liabilities		3,476,513		2,776,965
Total stockholders’ equity		1,150,341		504,488
Total liabilities and stockholders’ equity	$	4,626,854	$	3,281,453

Waters Corporation and Subsidiaries

Preliminary Condensed Consolidated Statements of Cash Flows

Three and Twelve Months Ended December 31, 2023 and December 31, 2022

(In thousands and unaudited)

	Three Months Ended						Twelve Months Ended
	December 31, 2023			December 31, 2022			December 31, 2023			December 31, 2022
Cash flows from operating activities:
Net income	$	216,205		$	227,062		$	642,234		$	707,755
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation		4,644			11,635			36,868			42,564
Depreciation and amortization		48,060			31,318			165,905			130,423
Change in operating assets and liabilities and other, net		(38,787	)		(71,306	)		(242,198	)		(269,081	)
Net cash provided by operating activities		230,122			198,709			602,809			611,661
Cash flows from investing activities:
Additions to property, plant, equipment and software capitalization		(41,588	)		(62,184	)		(160,632	)		(175,921	)
Business acquisitions, net of cash acquired		3,553			—			(1,282,354	)		—
Proceeds from equity investments, net		91			—			742			8,903
Payments for intellectual property licenses		—			—			—			(7,535	)
Net change in investments		—			—			(21	)		66,586
Net cash used in investing activities		(37,944	)		(62,184	)		(1,442,265	)		(107,967	)
Cash flows from financing activities:
Net change in debt		(150,001	)		30,000			779,600			60,000
Proceeds from stock plans		11,700			6,665			29,792			42,801
Purchases of treasury shares		156			(148,894	)		(70,277	)		(626,061	)
Other cash flow from financing activities, net		7,658			783			15,836			13,627
Net cash (used in) provided by financing activities		(130,487	)		(111,446	)		754,951			(509,633	)
Effect of exchange rate changes on cash and cash equivalents		(3,029	)		11,813			(948	)		(14,766	)
Increase (decrease) in cash and cash equivalents		58,662			36,892			(85,453	)		(20,705	)
Cash and cash equivalents at beginning of period		336,414			443,637			480,529			501,234
Cash and cash equivalents at end of period	$	395,076		$	480,529		$	395,076		$	480,529
Reconciliation of GAAP Cash Flows from Operating Activities to Free Cash Flow (a)
Net cash provided by operating activities - GAAP	$	230,122		$	198,709		$	602,809		$	611,661
Adjustments:
Additions to property, plant, equipment and software capitalization		(41,588	)		(62,184	)		(160,632	)		(175,921	)
Tax reform payments		—			—			72,101			38,454
Litigation settlements paid, net		(375	)		—			(1,500	)		(584	)
Major facility renovations		3,494			8,113			15,645			32,079
Payment of acquired Wyatt liabilities (b)		—			—			25,617			—
Free Cash Flow - Adjusted Non-GAAP	$	191,653		$	144,638		$	554,040		$	505,689

(a) The Company defines free cash flow as net cash flow from operations accounted for under GAAP less capital expenditures and software capitalizations plus or minus any unusual and non recurring items. Free cash flow is not a GAAP measurement and may not be comparable to free cash flow reported by other companies.

(b) In connection with the Wyatt acquisition, the Company assumed certain obligations of Wyatt and paid those obligations immediately upon closing the transaction. The Company believes that the assumed obligations do not represent future ongoing business expenses.

Waters Corporation and Subsidiaries

Reconciliation of Projected GAAP to Adjusted Non-GAAP Financial Outlook

	Three Months Ended March 30, 2024					Twelve Months Ended December 31, 2024
	Range					Range
Projected Sales
Organic constant currency sales growth rate (a)		(11.0%)	—		(9.0%)		(0.5%)	—		1.5%
Impact of:
Currency translation		(1.0%)	—		(1.0%)		(0.8%)	—		(0.8%)
Acquisitions		3.5%	—		3.5%		1.3%	—		1.3%
Sales growth rate as reported		(8.5%)	—		(6.5%)		0.0%	—		2.0%
	Range					Range
Projected Earnings Per Diluted Share
GAAP earnings per diluted share	$	1.77	—	$	1.87	$	10.80	—	$	11.10
Adjustments:
Purchased intangibles amortization	$	0.18	—	$	0.18	$	0.70	—	$	0.70
Retention bonus obligation	$	0.10	—	$	0.10	$	0.25	—	$	0.25
Adjusted non-GAAP earnings per diluted share	$	2.05	—	$	2.15	$	11.75	—	$	12.05

(a) Organic constant currency growth rates are a non-GAAP financial measure that measures the change in net sales between current and prior year periods, excluding the impact of foreign currency exchange rates during the current period and excluding the impact of acquisitions made within twelve months of the acquisition close date. These amounts are estimated at the current foreign currency exchange rates and based on the forecasted geographical sales in local currency, as well as an assessment of market conditions as of today, and may differ significantly from actual results.

These forward-looking adjustment estimates do not reflect future gains and charges that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance.